Anavex Life Sciences (AVXL) Payables (2011 - 2026)
Anavex Life Sciences' Payables came in at $3.66 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), down 45.8% from $6.74 million a year earlier but up 45.1% from the prior quarter.
Anavex Life Sciences (AVXL) Payables (2011 - 2026) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Anavex Life Sciences' Payables was $4.25 million, down 55.9% from FY2024.
- Payables carries a five-year compound annual growth rate of 1.3% (FY2020 to FY2025).
- Going back by fiscal year, Payables was $9.63 million in FY2024 (+122.7%), $4.32 million in FY2023 (+13.0%), $3.83 million in FY2022 (-19.3%) and $4.74 million in FY2021 (+18.8%).
- The five-year range for quarterly Payables is $2.52 million (fiscal Q2 2026) to $9.63 million (fiscal Q4 2024).
- Year-over-year, Payables has declined for four consecutive quarters, with growth averaging 12.7% over the last eight quarters.
- The fastest year-over-year change in Payables over five years came in fiscal Q2 2023 (growth of 138.7%), and the weakest in fiscal Q2 2026 (a decline of 64.0%).
- Business Quant data shows AVXL's Payables at $2.52 million (Q2 2026), $2.64 million (Q1 2026) and $4.25 million (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Anavex Life Sciences | 187.25 Mn | -292.83 Mn | - | 3.66 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.66 Mn |
| Mar 31, 2026 | 2.52 Mn |
| Dec 31, 2025 | 2.64 Mn |
| Sep 30, 2025 | 4.25 Mn |
| Jun 30, 2025 | 6.74 Mn |
| Mar 31, 2025 | 7.00 Mn |
| Dec 31, 2024 | 4.57 Mn |
| Sep 30, 2024 | 9.63 Mn |
| Jun 30, 2024 | 3.50 Mn |
| Mar 31, 2024 | 3.73 Mn |
| Dec 31, 2023 | 4.29 Mn |
| Sep 30, 2023 | 4.32 Mn |
| Jun 30, 2023 | 4.15 Mn |
| Mar 31, 2023 | 6.28 Mn |
| Dec 31, 2022 | 5.29 Mn |
| Sep 30, 2022 | 3.83 Mn |
| Jun 30, 2022 | 3.13 Mn |
| Mar 31, 2022 | 2.63 Mn |
| Dec 31, 2021 | 4.63 Mn |
| Sep 30, 2021 | 4.74 Mn |
Anavex Life Sciences Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=AVXL&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "AVXL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=AVXL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();